Meeting/Workshop

Meeting "Stress, barriers & neurological disorders"

November 25, 2021

Strasbourg (France)

INTRODUCTION

There is increasing evidence of a role of the microbiota gut brain axis in psychiatric, neurodevelopmental, age-related and neurodegenerative disorders. The existence of many common signaling molecules supports some reciprocal dialog between the gut, microbiota and brain. Nevertheless, compartmentalization of brain, systemic circulation and gut is required in order to maintain homeostasis of the host. Thus, specialized barriers such as the blood brain & blood CSF barrier isolate vulnerable neurons and brain cells from potential toxins and immune cells carried by systemic circulation. On the other hand, a gut barrier prevents the entry of potential pathogens and ingested toxins into systemic circulation. Could the breakdown or increased permeability of barriers be a critical step in the onset of some neurological diseases? Indeed, dysfunctions of the gut barrier are increasingly suggested to play a role in psychiatric disorders, such as depression or anxiety, to cite only a few, while a breakdown of the BBB is central to the inflammatory component of neurological diseases such as MS or stroke, for example.

Are indeed these barriers so -anatomically and structurally- different? Could their comparison highlight some common pathways of vulnerability? The gut immune barrier and BBB may be compromised by many means, including chemical and psychological stress, while inflammation plays a deleterious role.

Understanding the mechanisms that control the formation, function and vulnerability of each barrier, as well as their interrelationship should provide some invaluable insights into key pathophysiological pathways.